Published in Stroke on May 01, 2012
Effect of electroacupuncture on rat ischemic brain injury: importance of stimulation duration. Evid Based Complement Alternat Med (2013) 0.90
Endovascular treatment for acute ischemic stroke patients: implications and interpretation of IMS III, MR RESCUE, and SYNTHESIS EXPANSION trials: A report from the Working Group of International Congress of Interventional Neurology. J Vasc Interv Neurol (2014) 0.84
Inhibition of retinoblastoma mRNA degradation through Poly (A) involved in the neuroprotective effect of berberine against cerebral ischemia. PLoS One (2014) 0.81
Mechanical thrombectomy using a combined CT/C-arm X-ray system. J Neurointerv Surg (2015) 0.78
Reperfusion therapy of acute ischaemic stroke and acute myocardial infarction: similarities and differences. Eur Heart J (2013) 0.78
Catheter-based interventions for acute ischaemic stroke. Eur Heart J (2015) 0.78
Electro-acupuncture exerts beneficial effects against cerebral ischemia and promotes the proliferation of neural progenitor cells in the cortical peri-infarct area through the Wnt/β-catenin signaling pathway. Int J Mol Med (2015) 0.77
Clinical and magnetic resonance imaging predictors of very early neurological response to intravenous thrombolysis in patients with middle cerebral artery occlusion. J Am Heart Assoc (2013) 0.77
Mechanical thrombectomy - an alternative treatment option in a patient with acute ischemic stroke and multiple contraindications for systemic thrombolysis: a case report. J Med Case Rep (2013) 0.75
Safety of tirofiban for patients with acute ischemic stroke in routine clinical practice. Exp Ther Med (2015) 0.75
Intra-arterial therapy as a rescue strategy after clinically failed intravenous thrombolysis may increase the likelihood of a good outcome in patients with severe ischaemic stroke. A retrospective two centre study. Interv Neuroradiol (2014) 0.75
Does Antiplatelet Therapy during Bridging Thrombolysis Increase Rates of Intracerebral Hemorrhage in Stroke Patients? PLoS One (2017) 0.75
Lipoprotein(a) as a cardiovascular risk factor: current status. Eur Heart J (2010) 4.31
Comparison of intravenous alteplase with a combined intravenous-endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study. Lancet Neurol (2009) 3.88
A transient ischaemic attack clinic with round-the-clock access (SOS-TIA): feasibility and effects. Lancet Neurol (2007) 3.56
Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management. Eur Heart J (2011) 3.00
Addition of brain and carotid imaging to the ABCD² score to identify patients at early risk of stroke after transient ischaemic attack: a multicentre observational study. Lancet Neurol (2010) 2.87
A review of the evidence for the use of telemedicine within stroke systems of care: a scientific statement from the American Heart Association/American Stroke Association. Stroke (2009) 2.74
Atherosclerotic disease of the aortic arch as a risk factor for recurrent ischemic stroke. The French Study of Aortic Plaques in Stroke Group. N Engl J Med (1996) 2.55
Statin treatment and stroke outcome in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke (2009) 2.51
New England Medical Center Posterior Circulation registry. Ann Neurol (2004) 2.42
Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis. Stroke (2004) 2.41
Intracranial arterial dolichoectasia and small-vessel disease in stroke patients. Ann Neurol (2005) 2.36
Lipid management in the prevention of stroke: review and updated meta-analysis of statins for stroke prevention. Lancet Neurol (2009) 2.33
Recommendations for the implementation of telemedicine within stroke systems of care: a policy statement from the American Heart Association. Stroke (2009) 2.26
Intracranial arterial dolichoectasia and its relation with atherosclerosis and stroke subtype. Neurology (2003) 2.22
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial. Lancet (2011) 2.16
Placebo-controlled trial of high-dose atorvastatin in patients with severe cerebral small vessel disease. Stroke (2009) 2.10
Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 2.06
Prevalence of coronary atherosclerosis in patients with cerebral infarction. Stroke (2010) 1.88
Yield of systematic transcranial Doppler in patients with transient ischemic attack. Ann Neurol (2010) 1.85
Association between influenza vaccination and reduced risk of brain infarction. Stroke (2002) 1.81
Stroke research priorities for the next decade--A representative view of the European scientific community. Cerebrovasc Dis (2006) 1.75
Antithrombotic and thrombolytic therapy for ischemic stroke: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest (2004) 1.64
Randomized, double-blind, placebo-controlled, international trial of the oral IIb/IIIa antagonist lotrafiban in coronary and cerebrovascular disease. Circulation (2003) 1.63
Carotid intima-media thickness, plaques, and Framingham risk score as independent determinants of stroke risk. Stroke (2005) 1.52
Medical treatment in acute and long-term secondary prevention after transient ischaemic attack and ischaemic stroke. Lancet (2011) 1.46
Concurrent dolichoectasia of basilar and coronary arteries. Neurology (2005) 1.44
Aortic arch atheroma in transient ischemic attack patients. Atherosclerosis (2013) 1.43
Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation (2013) 1.41
Meta-analysis of the effect of nicotinic acid alone or in combination on cardiovascular events and atherosclerosis. Atherosclerosis (2009) 1.36
Autopsy prevalence of intracranial atherosclerosis in patients with fatal stroke. Stroke (2008) 1.36
Addition of brain infarction to the ABCD2 Score (ABCD2I): a collaborative analysis of unpublished data on 4574 patients. Stroke (2010) 1.35
High-density lipoprotein-cholesterol and risk of stroke and carotid atherosclerosis: a systematic review. Atherosclerosis (2007) 1.30
Basilar artery atherosclerotic plaques in paramedian and lacunar pontine infarctions: a high-resolution MRI study. Stroke (2010) 1.30
Residual macrovascular risk in 2013: what have we learned? Cardiovasc Diabetol (2014) 1.20
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. Circulation (2013) 1.20
Insular involvement in brain infarction increases risk for cardiac arrhythmia and death. Ann Neurol (2006) 1.18
Ischemia-modified albumin in acute stroke. Cerebrovasc Dis (2006) 1.17
Does ABCD2 score below 4 allow more time to evaluate patients with a transient ischemic attack? Stroke (2009) 1.16
Costs of stroke care according to handicap levels and stroke subtypes. Cerebrovasc Dis (2003) 1.14
High-resolution MRI identifies basilar artery plaques in paramedian pontine infarct. Neurology (2005) 1.14
Cerebral microbleeds are frequent in infective endocarditis: a case-control study. Stroke (2009) 1.13
Thrombospondin-1 is a plasmatic marker of peripheral arterial disease that modulates endothelial progenitor cell angiogenic properties. Arterioscler Thromb Vasc Biol (2010) 1.11
Patients with transient ischemic attack with ABCD2 <4 can have similar 90-day stroke risk as patients with transient ischemic attack with ABCD2 ≥4. Stroke (2011) 1.06
Peripheral artery disease is associated with a high CD163/TWEAK plasma ratio. Arterioscler Thromb Vasc Biol (2010) 1.05
Polymorphism R92Q of the tumour necrosis factor receptor 1 gene is associated with myocardial infarction and carotid intima-media thickness--the ECTIM, AXA, EVA and GENIC Studies. Eur J Hum Genet (2004) 1.04
Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke (2006) 1.02
Plasma triglyceride levels and risk of stroke and carotid atherosclerosis: a systematic review of the epidemiological studies. Atherosclerosis (2008) 1.02
Fibrates effect on cardiovascular risk is greater in patients with high triglyceride levels or atherogenic dyslipidemia profile: a systematic review and meta-analysis. J Cardiovasc Pharmacol (2011) 1.01
Basilar artery diameter and 5-year mortality in patients with stroke. Stroke (2006) 1.00
Carotid artery intima media thickness, plaque and Framingham cardiovascular score in Asia, Africa/Middle East and Latin America: the PARC-AALA study. Int J Cardiovasc Imaging (2006) 0.99
Diabetes mellitus, admission glucose, and outcomes after stroke thrombolysis: a registry and systematic review. Stroke (2013) 0.97
Adverse associations between CX3CR1 polymorphisms and risk of cardiovascular or cerebrovascular disease. Arterioscler Thromb Vasc Biol (2005) 0.96
Outcomes of intravenous recombinant tissue plasminogen activator therapy according to gender: a clinical registry study and systematic review. Stroke (2009) 0.96
Autopsy prevalence of coronary atherosclerosis in patients with fatal stroke. Stroke (2007) 0.96
Is moderate atherosclerotic stenosis in the middle cerebral artery a cause of or a coincidental finding in ischemic stroke? Cerebrovasc Dis (2009) 0.95
Atherogenic dyslipidemia and residual cardiovascular risk in statin-treated patients. Stroke (2014) 0.95
Determinants of outcome and safety of intravenous rt-PA therapy in the very old: a clinical registry study and systematic review. Age Ageing (2007) 0.94
Outcomes of mechanical endovascular therapy for acute ischemic stroke: a clinical registry study and systematic review. Stroke (2011) 0.92
Renin-angiotensin-aldosterone system in brain infarction and vascular death. Ann Neurol (2005) 0.92